Accenture invests in Ocean Genomics
DUBLIN, IRELAND — Leading IT firm Accenture, which recently ranked Top 1 in the Time Doctor OA500, has invested in Ocean Genomics.
Terms of the investment were not disclosed.
The strategic investment aims to advance AI-driven drug discovery and develop personalized medicines.
Ocean Genomics, a Pennsylvania-based tech and AI company, develops software for biopharma firms that develop treatments based on a person’s biology.
Accenture is a global firm that provides a broad range of services across technology, consulting, and operations, among others. The company employs 738,000 people in over 120 countries.
